Setbacks For China Pharma As Firms Hit With Antitrust Fine, Clinical Setback

 
• By Brian Yang
  
china and antitrust
YANGZTE RIVE PHARMA BECOMES THE TARGET IN CHINA ANTITRUST CRACKDOWN • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia